Cyril Amarchand Mangaldas advises Book Running Lead Managers on IPO undertaken by Juniper Green Energy Ltd.
The Company is among the top 10 largest renewable independent power producers in India by total capacity as at March 31, 2026.
Capital Markets
Cyril Amarchand Mangaldas acts as Indian legal counsel to Lohia Corp Ltd. on its IPO
CAM also advised Amit Kumar Lohia and Gaurav Lohia, promoters of the Company, and certain other shareholders of the Company in their secondary Pre-IPO sale of Equity Shares of the Company aggregating to ₹2,949.50 million.
Shardul Amarchand Mangaldas advises Juniper Green Energy Ltd. on its ₹18,000.00 million IPO
The equity shares of Juniper Green Energy Limited were listed on BSE Limited and the National Stock Exchange of India Limited on 6 August 2026.
Cyril Amarchand Mangaldas advises Cube Highways Trust on India’s first conversion of a privately listed InvIT into a publicly listed InvIT
The transaction involved an offer for sale of approximately INR 5,000 crore, undertaken by BCI IRR India Holdings Inc., BCI IRR India Holdings Limited Partnership, Cube Highways and Infrastructure II Pte. Ltd., Cube Highways and Infrastructure III Pte. Ltd., Cube Mobility Investments Pte. Ltd. and Seventy Second Investment Company LLC.
Shardul Amarchand Mangaldas & Co. advises on Cube Highways Trust’s conversion into a publicly listed InvIT and its ₹50,000 million IPO
The transaction marks the first successful conversion of a privately listed InvIT into a publicly listed InvIT in India, representing a significant milestone in the evolution of India’s listed infrastructure investment market. Continuing its streak, SAM has acted on every public offering by an InvIT/REIT this calendar year.
Cyril Amarchand Mangaldas acts as Indian legal counsel to Manipal Health Enterprises Limited on its IPO
The Company operates India’s largest multispecialty hospital network by bed capacity and the second largest hospital chain by number of hospitals. The book running lead managers on this deal were Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Limited.
S&R Associates advises UltraTech Cement on INR 50 billion listed NCD issuance through private placement
S&R Associates advised UltraTech Cement Limited on its INR 50 billion issuance of listed non-convertible debentures through private placement.
Shardul Amarchand Mangaldas & Co. advises Mubadala on Manipal Health Enterprises’ IPO
The equity shares of Manipal Health Enterprises Limited were listed on BSE Limited and the National Stock Exchange of India Limited on 5 August 2026.
CAM advises Elevation Capital V Limited, SAIF III Mauritius Company Ltd. and SAIF Partners India IV Ltd. on block sale of equity shares of One97 Communications Ltd.
Cyril Amarchand Mangaldas advised Elevation Capital V Limited, SAIF III Mauritius Company Ltd. and SAIF Partners India IV Ltd. on the block sale of equity shares of One97 Communications Ltd.
S&R Associates Advises Equirus Capital and Motilal Oswal on Lohia Corp’s ₹11.01 Billion IPO
S&R Associates advised Equirus Capital and Motilal Oswal, the book running lead managers, on Lohia Corp Limited’s ₹11.01 billion initial public offering.
SAM advises Continuum Group on USD 450 million Senior Unsecured Reg S/144A Bond Issuance through its global treasury centre in GIFT City
SAM advised on all aspects of Indian law relating to the transaction, including the regulatory framework applicable to the issuer under the GIFT City IFSC regime, the structuring of the offering, the review, negotiation and finalisation of the offering circular and transaction documents, including the bond documentation, trust deeds and corporate guarantees. SAM also acted as the listing agent for the listing of the Bonds on NSE IX.
SAM advises Underwriters on SBI Funds Management’s ₹ 11,675.29 cr IPO including pre-IPO sales of ₹ 1,879.97 cr by promoter selling shareholders
The IPO is the largest public offering in India in 2026 to date and marks a significant milestone for the Indian capital markets. The equity shares were listed on the stock exchanges on 21 July 2026.
S&R Associates advises Amundi Group on SBI Funds Management’s IPO and Pre-IPO Secondary Sales
The aggregate proceeds to Amundi and SBI were INR 116.75 billion (approx. US$ 1.21 billion), with INR 97.95 billion (approx. US$ 1.02 billion) raised in the IPO and INR 18.80 billion (approx. US$ 195.25 million) in the pre-IPO secondary sales.
Shardul Amarchand Mangaldas Advises Ather Energy on ₹1,300 Crore Qualified Institutions Placement
The issue was priced at a 2.76% premium to the floor price determined in accordance with applicable law and saw participation from marquee institutional investors, including ADIA and affiliates of mutual funds and insurance companies such as ICICI Prudential Life Insurance, HDFC Life Insurance, LIC Mutual Fund, Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund and HSBC Mutual Fund, among others.
S&R Strengthens Capital Markets Practice with Three Key Partner Appointments
S&R Associates has announced the appointment of Reuben Chacko as a Partner in its Bengaluru office, along with the induction of Rushab Dhandokia and Aniran Ghoshal as Retained Partners in its Mumbai office, further strengthening the firm’s capital markets practice.
Cyril Amarchand Mangaldas advises Motilal Oswal Investment Advisor and ICICI Securities on QIP of Blue Jet Healthcare
The QIP was undertaken to ensure compliance with the minimum public shareholding as prescribed under the Securities Contracts (Regulations) Rules, 1957.
Cyril Amarchand Mangaldas advises Adani Enterprises on its Qualified Institutional Placement
CAM had also advised on the previous qualified institutional placement undertaken by Adani Enterprises Limited in October 2024.
Cyril Amarchand Mangaldas advises on qualified institutions placement of Sterlite Technologies Ltd.
The proceeds of the QIP are proposed to be utilized towards re-payment and /or prepayment of certain outstanding borrowings of the Company and certain of its subsidiaries, and general corporate purposes.
Cyril Amarchand Mangaldas advised on the initial public offering of equity shares of Turtlemint Fintech Solutions Ltd.
Turtlemint is a tech-enabled insurance distribution platform that connects customers, insurance advisors and insurers, offering retail insurance products and other financial products on its platform.
Cyril Amarchand Mangaldas advises on the QIP of Krishna Institute of Medical Sciences Ltd.
The proceeds of the QIP are proposed to be utilized towards re-payment and /or prepayment of certain outstanding borrowings of the Company and certain of its subsidiaries, and general corporate purposes.